Literature DB >> 30699268

Incidence of external genital lesions related to human papillomavirus among Mexican men. A cohort study.

Eduardo Lazcano-Ponce1, Staci L Sudenga2, B Nelson Torres2, Mark Stoler3, Leith León-Maldonado4, Betania Allen-Leigh5, Héctor Posso6, Manuel Quiterio1, María Del Pilar Hernández-Nevarez1, Jorge Salmerón1,7, Anna R Giuliano2.   

Abstract

OBJECTIVE: To determine external genital lesion (EGL) incidence -condyloma and penile intraepithelial neoplasia (PeIN)- and genital HPV-genotype progression to these EGLs.
MATERIALS AND METHODS: Participants (healthy males 18- 74y from Cuernavaca, Mexico, recruited 2005-2009, n=954) underwent a questionnaire, anogenital examination, and sample collection every six months;including excision biopsy on suspicious EGL with histological confirmation.Linear array assay PCR characterized 37 high/low-risk HPV-DNA types. EGL incidence and cumulative incidence were calculated, the latter with Kaplan-Meier.
RESULTS: EGL incidence was 1.84 (95%CI=1.42-2.39) per 100-person-years (py); 2.9% (95%CI=1.9-4.2) 12-month cumulative EGL.Highest EGL inci- dence was found in men 18-30 years:1.99 (95%CI=1.22-3.25) per 100py. Seven subjects had PeIN I-III (four with HPV16). HPV11 most commonly progresses to condyloma (6-month cumulative incidence=44.4%, 95%CI=14.3-137.8). Subject with high-risk sexual behavior had higher EGL incidence.
CONCLUSIONS: In Mexico, anogenital HPV infection in men is high and can cause condyloma. Estimation of EGL magnitude and associated healthcare costs is necessary to assess the need for male anti-HPV vaccination.

Entities:  

Keywords:  condylomata acuminata; genital warts; penile neoplasm

Mesh:

Year:  2018        PMID: 30699268      PMCID: PMC6642747          DOI: 10.21149/8461

Source DB:  PubMed          Journal:  Salud Publica Mex        ISSN: 0036-3634


  37 in total

1.  Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test.

Authors:  François Coutlée; Danielle Rouleau; Patrick Petignat; Georges Ghattas; Janet R Kornegay; Peter Schlag; Sean Boyle; Catherine Hankins; Sylvie Vézina; Pierre Coté; John Macleod; Hélène Voyer; Pierre Forest; Sharon Walmsley; Eduardo Franco
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

2.  Carcinogenicity of human papillomaviruses.

Authors:  Vincent Cogliano; Robert Baan; Kurt Straif; Yann Grosse; Béatrice Secretan; Fatiha El Ghissassi
Journal:  Lancet Oncol       Date:  2005-04       Impact factor: 41.316

3.  [Prevalence of condyloma acuminata in women who went to opportune detection of cervicouterine cancer].

Authors:  Carlos Ramón Jiménez-Vieyra
Journal:  Ginecol Obstet Mex       Date:  2010-02

4.  Circumcision and sexual behavior: factors independently associated with human papillomavirus detection among men in the HIM study.

Authors:  Anna R Giuliano; Eduardo Lazcano; Luisa Lina Villa; Roberto Flores; Jorge Salmeron; Ji-Hyun Lee; Mary Papenfuss; Martha Abrahamsen; Maria Luiza Baggio; Roberto Silva; Manuel Quiterio
Journal:  Int J Cancer       Date:  2009-03-15       Impact factor: 7.396

5.  The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries.

Authors:  Susanne Krüger Kjaer; Trung Nam Tran; Par Sparen; Laufey Tryggvadottir; Christian Munk; Erik Dasbach; Kai-Li Liaw; Jan Nygård; Mari Nygård
Journal:  J Infect Dis       Date:  2007-10-31       Impact factor: 5.226

6.  Genital warts among 18- to 59-year-olds in the United States, national health and nutrition examination survey, 1999--2004.

Authors:  Thu-Ha Dinh; Maya Sternberg; Eileen F Dunne; Lauri E Markowitz
Journal:  Sex Transm Dis       Date:  2008-04       Impact factor: 2.830

7.  Impact of a quadrivalent HPV6/11/16/18 vaccine in Mexican women: public health implications for the region.

Authors:  Eduardo Lazcano-Ponce; Gonzalo Pérez; Aurelio Cruz-Valdez; Laura Zamilpa; Carlos Aranda-Flores; Pilar Hernández-Nevarez; Jose Luis Viramontes; Joaquín Salgado-Hernández; Margaret James; Shuang Lu; Carlos Sattler; Richard M Haupt; Mauricio Hernández-Avila
Journal:  Arch Med Res       Date:  2009-08       Impact factor: 2.235

Review 8.  The role of HPV type in Recurrent Respiratory Papillomatosis.

Authors:  A J Donne; L Hampson; J J Homer; I N Hampson
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2009-10-01       Impact factor: 1.675

9.  Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine.

Authors:  Suzanne M Garland; Marc Steben; Heather L Sings; Margaret James; Shuang Lu; Radha Railkar; Eliav Barr; Richard M Haupt; Elmar A Joura
Journal:  J Infect Dis       Date:  2009-03-15       Impact factor: 5.226

10.  Incidence of anogenital warts in Germany: a population-based cohort study.

Authors:  Angela A Kraut; Tania Schink; Renate Schulze-Rath; Rafael T Mikolajczyk; Edeltraut Garbe
Journal:  BMC Infect Dis       Date:  2010-12-23       Impact factor: 3.090

View more
  2 in total

1.  Uptake of the HPV vaccine among people with and without HIV, cisgender and transgender women and men who have sex with men and with women at two sexual health clinics in Mexico City.

Authors:  Betania Allen-Leigh; Leonor Rivera-Rivera; Elsa Yunes-Díaz; Alejandra Jalil Portillo-Romero; Brandon Brown; Leith León-Maldonado; Galileo Vargas-Guadarrama; Jorge Salmerón; Eduardo Cesar Lazcano-Ponce
Journal:  Hum Vaccin Immunother       Date:  2019-11-01       Impact factor: 3.452

2.  Sex differences in the prevalence and determinants of HPV-related external genital lesions in young adults: a national cross-sectional survey in Brazil.

Authors:  Juliana Comerlato; Natália Luiza Kops; Marina Bessel; Jaqueline Driemeyer Horvath; Bruna Vieira Fernandes; Luisa Lina Villa; Flavia Moreno Alves de Souza; Gerson Fernando Mendes Pereira; Eliana Márcia Wendland
Journal:  BMC Infect Dis       Date:  2020-09-18       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.